Literature DB >> 7717130

Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages.

J T Leith1, S Cook, P Chougule, P Calabresi, L Wahlberg, C Lindquist, M Epstein.   

Abstract

UNLABELLED: We have collected the in vitro x-ray radiation survival characteristics of 181 lines from 12 different classes of exponentially growing human tumor cells (sarcomas, lung cancers, colo-rectal cancers, medulloblastomas, melanoma, breast cancers, prostate cancers, renal cell cancers, grades III and IV brain tumors, ovarian, and head and neck cancers). This information was used to intercompare survival after single high doses of 20-40 Gy for each tumor line. Radiosensitivities could roughly be divided into two groups. The more radiosensitive group included: sarcoma, small-cell lung cancer, non-small cell lung cancer, colorectal cancer, medulloblastoma and melanoma. The more radioresistant group included breast, prostate, renal cell, primary brain tumors, ovarian tumors, and head and neck cancers. Using a model of a 3 cm diameter brain lesion containing about 1.4 x 10(9) oxic cells, the single doses calculated to reduce survival to 1 cell were: sarcoma and small cell lung cancers-22-23 Gy; melanoma-25 Gy; non-small cell lung and colorectal cancer-26 Gy; medullo-blastoma-28 Gy; breast, prostate, renal cell, primary brain tumors, ovarian tumors, and head and neck cancers-30-36 Gy. If, however, tumors contained on average 20 percent hypoxic cells, the dose needed for equivalent cell killing increased by about a factor of 2.6-2.8. Also, there was no correlation between the ranking of relative radiosensitivities of the various classes of tumor cells at high doses (as in radiosurgery) to the sensitivity at low doses (as in conventional fractionated radiotherapy).
CONCLUSION: available information on the intrinsic radiosensitivity of human tumor cells indicates that meaningful differences exist among different histological classes of neoplasm that are relevant to the single high doses used in radioneurosurgery, and which could constitute a basis for "tailoring" the administered dose to the particular neoplasm. However, if intracerebral lesions contain a large number of hypoxic cells (e.g., 20%), this may constitute a significant problem.

Entities:  

Mesh:

Year:  1994        PMID: 7717130     DOI: 10.1007/978-3-7091-9371-6_5

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  17 in total

1.  Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.

Authors:  Chang W Song; Yoon-Jin Lee; Robert J Griffin; Inhwan Park; Nathan A Koonce; Susanta Hui; Mi-Sook Kim; Kathryn E Dusenbery; Paul W Sperduto; L Chinsoo Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-16       Impact factor: 7.038

2.  A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis.

Authors:  Daniela Greto; Stefania Pallotta; Laura Masi; Cinzia Talamonti; Livia Marrazzo; Raffaella Doro; Calogero Saieva; Silvia Scoccianti; Isacco Desideri; Lorenzo Livi
Journal:  Radiol Med       Date:  2017-02-15       Impact factor: 3.469

Review 3.  Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

Authors:  Katherine D Castle; David G Kirsch
Journal:  Cancer Res       Date:  2019-08-19       Impact factor: 12.701

4.  Deletion of Atm in Tumor but not Endothelial Cells Improves Radiation Response in a Primary Mouse Model of Lung Adenocarcinoma.

Authors:  Jordan A Torok; Patrick Oh; Katherine D Castle; Michael Reinsvold; Yan Ma; Lixia Luo; Chang-Lung Lee; David G Kirsch
Journal:  Cancer Res       Date:  2018-10-12       Impact factor: 12.701

5.  Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.

Authors:  Chiachien Jake Wang; Alana Christie; Mu-Han Lin; Matthew Jung; Derek Weix; Lorel Huelsmann; Kristin Kuhn; Jeffrey Meyer; Neil Desai; D W Nathan Kim; Ivan Pedrosa; Vitaly Margulis; Jeffrey Cadeddu; Arthur Sagalowsky; Jeffrey Gahan; Aaron Laine; Xian-Jin Xie; Hak Choy; James Brugarolas; Robert Timmerman; Raquibul Hannan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-01       Impact factor: 7.038

6.  Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.

Authors:  Francesca Pistollato; Elena Rampazzo; Luca Persano; Sara Abbadi; Chiara Frasson; Luca Denaro; Domenico D'Avella; David M Panchision; Alessandro Della Puppa; Renato Scienza; Giuseppe Basso
Journal:  Stem Cells       Date:  2010-11       Impact factor: 6.277

7.  Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis.

Authors:  Berndt Wowra; Alexander Muacevic; Jörg-Christian Tonn
Journal:  J Neurooncol       Date:  2009-02-01       Impact factor: 4.130

Review 8.  Radiobiological basis of SBRT and SRS.

Authors:  Chang W Song; Mi-Sook Kim; L Chinsoo Cho; Kathryn Dusenbery; Paul W Sperduto
Journal:  Int J Clin Oncol       Date:  2014-07-05       Impact factor: 3.402

9.  Intractable vomiting as an early clinical symptom of cerebrospinal fluid seeding to the fourth ventricle in patients with high-grade astrocytoma.

Authors:  Miki Fujimura; Toshihiro Kumabe; Hidefumi Jokura; Reizo Shirane; Takashi Yoshimoto; Teiji Tominaga
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

10.  Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with Dodecafluoropentane Nano-Emulsion-Preliminary Findings.

Authors:  Jennifer L H Johnson; Rafael A Leos; Amanda F Baker; Evan C Unger
Journal:  J Biomed Nanotechnol       Date:  2015-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.